Neuropace Inc (NPCE)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $260.45M
Last updated: Nov 17, 2026 at 4:30 PM ET
Neuropace Inc (NPCE) Stock Chart
Neuropace (NPCE) has a latest price of $8.20 on Nov 17, 2026, 58.2% below its 52-week high of $19.60. Its price fell 36.6% over the past 12 months. The month-end price fell 18.9% over the 5 years through Oct 2026, a compound annual decline of 4.1%.
Price Chart
From Apr 2021 to Oct 2026, its highest month-end close was $24.16 in Apr 2021 and its lowest $1.49 in Dec 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NPCE with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NPCE.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 44.0%, and over 6 months it fell 48.3%. The month-end price rose 82.2% over the 3 years through Oct 2026, a compound annual rate of 22.1%.
| Period | Change |
|---|---|
| 1 month | -35.8% |
| 3 months | -44.0% |
| 6 months | -48.3% |
| 12 months | -36.6% |
| 12 months, with dividends | -36.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +82.2% | +22.1% |
| 5 years | -18.9% | -4.1% |
Price by Year
Its best calendar year was 2023, when the price rose 591.9%, and its weakest was 2022, when it fell 85.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $12.30 | -20.3% |
| 2025 | $15.44 | +38.0% |
| 2024 | $11.19 | +8.5% |
| 2023 | $10.31 | +591.9% |
| 2022 | $1.49 | -85.2% |
Trading Range
The price is 36.6% below its 50-day average of $12.94 and 44.2% below its 200-day average of $14.69.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $8.20 | |
| 52-week high | $19.60 | -58.2% |
| 52-week low | $5.46 | +50.2% |
| 50-day average | $12.94 | -36.6% |
| 200-day average | $14.69 | -44.2% |
Price Risk
Over 3 years, its largest fall from a peak was 66.3%.
| Measure | Value |
|---|---|
| 1-year beta | 1.35 |
| Largest fall, 1 year | -60.8% |
| Largest fall, 3 years | -66.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NPCE
What is NPCE's 1-year price change?
Neuropace's price fell 36.6% over the past 12 months. With dividends included, the 12-month total return was -36.6%.
What is NPCE's 5-year price change?
Neuropace's month-end price fell 18.9% over the 5 years through Oct 2026, a compound annual decline of 4.1%. These figures leave out dividends.
What is NPCE's 52-week high and low?
Neuropace's 52-week high is $19.60 and its 52-week low is $5.46. Its latest price of $8.20 on Nov 17, 2026 is 58.2% below the high.
What is NPCE's beta?
Neuropace's 1-year beta against the S&P 500 is 1.35, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 60.8%.
Is the NPCE chart free?
Yes. Advanced Charting for NPCE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NPCE pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts